Literature DB >> 27838346

Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.

Janine Gericke1, Martin Metz1, Tatevik Ohanyan1, Karsten Weller1, Sabine Altrichter1, Per Stahl Skov2, Sidsel Falkencrone3, Janko Brand4, Arno Kromminga5, Tomasz Hawro1, Martin K Church1, Marcus Maurer6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27838346     DOI： 10.1016/j.jaci.2016.07.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  24 in total

Review 1.  Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

Authors:  Michael D Tharp; Jonathan A Bernstein; Abhishek Kavati; Benjamin Ortiz; Karen MacDonald; Kris Denhaerynck; Ivo Abraham; Christopher S Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  New insights into the utility of omalizumab.

Authors:  Juan Carlos Cardet; Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2019-01-26       Impact factor: 10.793

Review 3.  [Angioedema prophylaxis].

Authors:  V Zampeli; M Magerl
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

Review 4.  Pruritus in allergy and immunology.

Authors:  Ting-Lin B Yang; Brian S Kim
Journal:  J Allergy Clin Immunol       Date:  2019-08       Impact factor: 10.793

Review 5.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 6.  Urticaria.

Authors:  Pavel Kolkhir; Ana M Giménez-Arnau; Kanokvalai Kulthanan; Jonny Peter; Martin Metz; Marcus Maurer
Journal:  Nat Rev Dis Primers       Date:  2022-09-15       Impact factor: 65.038

Review 7.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Marcus Maurer; Kilian Eyerich; Stefanie Eyerich; Marta Ferrer; Jan Gutermuth; Karin Hartmann; Thilo Jakob; Alexander Kapp; Pavel Kolkhir; Désirée Larenas-Linnemann; Hae-Sim Park; Gunnar Pejler; Mario Sánchez-Borges; Knut Schäkel; Dagmar Simon; Hans-Uwe Simon; Karsten Weller; Torsten Zuberbier; Martin Metz
Journal:  Int Arch Allergy Immunol       Date:  2020-03-30       Impact factor: 2.749

8.  Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.

Authors:  R Asero; A V Marzano; S Ferrucci; M Lorini; V Carbonelli; M Cugno
Journal:  Clin Exp Immunol       Date:  2020-03-17       Impact factor: 4.330

Review 9.  Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.

Authors:  Désirée E S Larenas-Linnemann; Claudio A S Parisi; Carla Ritchie; Ricardo Cardona-Villa; Ivan Cherrez-Ojeda; Annia Cherrez; Luis Felipe Ensina; Elizabeth Garcia; Iris V Medina; Mónica Rodríguez-González; Jorge Mario Sánchez Caraballo
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-09       Impact factor: 4.806

Review 10.  Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors:  Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-16       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.